Tumor-associated macrophage polarization in the inflammatory tumor microenvironment
Open accessThe DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Abstract
The chronic inflammation of tumor continues to recruit TAMs (tumor−associated macrophages) to the TME (tumor microenvironment) and promote polarization. Pro-inflammatory signals polarize macrophages to the M1 phenotype to enhance inflammation against pathogens. Tumor inflammatory development changes the pro-inflammatory response to an anti-inflammatory response, resulting in the alteration of macrophages from M1 to M2 to promote tumor progression. Additionally, hypoxia activates HIF (hypoxia-inducible factors) in the TME, which reprograms macrophages to the M2 phenotype to support tumor development. Here, we discuss the factors that drive phenotypic changes in TAMs in the inflammatory TME, which will help in the development of cancer immunotherapy of macrophages.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both HIF-1α or HIF-2α expression in TAMs have been associated with tumor progression and/or poor prognosis in multiple tumor types, whereas lack of HIF-1α or HIF-2α in TAMs decreases metastasis, cell proliferation, and expression of pro-inflammatory cytokines such as IL-6 [73–76].”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [74]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both HIF-1α or HIF-2α expression in TAMs have been associated with tumor progression and/or poor prognosis in multiple tumor types, whereas lack of HIF-1α or HIF-2α in TAMs decreases metastasis, cell proliferation, and expression of pro-inflammatory cytokines such as IL-6 [73–76].”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [74]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
RETRACTED: FoxP3 Acts as a Cotranscription Factor with STAT3 in Tumor-Induced Regulatory T Cells
Hossain, D. M. S., Panda, A. K., Manna, A., Mohanty, S., Bhattacharjee, P., Bhattacharyya, S., Saha, T., Chakraborty, S., Kar, R. K., Das, T., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.11.005 · Cited by 120
RetractedWu, J., Zhang, J., Shen, B., Yin, K., Xu, J., Gao, W., & Zhang, L. (2015) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-015-0229-3 · Cited by 117 · cited 1×
“For example, when TAMs are cocultured with hepatoma cells, macrophage-derived IL-6 and IL-8 activate JAK kinase, which phosphorylates STAT3 activating STAT3 signaling in tumor cells and promotes the epithelial mesenchymal transition(EMT), thus enhancing tumor invasion and metastasis (33, 34).”
BackgroundRetractedMyeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753 · cited 2×
“MDSCs also express high levels of arginase-1, which promote macrophage polarization and contribute to immune suppression (8, 43, 44).”
BackgroundProtective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269 · cited 1×
“But the chronic inflammation leads to the production of antiinflammatory signals and the transition of macrophages from the M1 to anti-inflammatory M2 phenotype to prevent excess inflammation from occurring (14).”
BackgroundIL‐6 in inflammation, immunity, and disease
Tanaka, T., Narazaki, M., & Kishimoto, T. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016295 · Cited by 5,046 · cited 1×
“In inflammatory TME, IL-6 secreted by TAMs resulting in a vicious cycle that further promote macrophages polarization to TAMS and increase IL-6 expression which can lead to a smoldering inflammatory state, and enhance tumor cell metastasis (46, 59).”
BackgroundTumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089
Tumour-associated macrophages as treatment targets in oncology
Mantovani, A., Marchesi, F., Malesci, A., Laghi, L., & Allavena, P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.217 · Cited by 4,033 · cited 1×
“Clinical studies indicated that single-agent carlumab only temporarily repressed serum CCL2, resulting in no significant antitumor effects (76).”
BackgroundTargeting the IL-6/JAK/STAT3 signalling axis in cancer
Johnson, D. E., O'Keefe, R. A., & Grandis, J. R. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.8 · Cited by 3,110 · cited 1×
“IL-6 acts on IL-6R/gp130 receptors and active STAT3 signaling which can promote epithelial-mesenchymal transition (EMT), angiogenesis and immunosuppression in cancers (61).”
BackgroundFunctional Polarization of Tumour-Associated Macrophages by Tumour-Derived Lactic Acid
Colegio, O. R., Chu, N.-Q., Szabo, A. L., Chu, T., Rhebergen, A. M., Jairam, V., Cyrus, N., Brokowski, C. E., Eisenbarth, S. C., Phillips, G. M., et al. (2014) · Nature · doi:10.1038/nature13490 · Cited by 3,046 · cited 1×
“It was found that coculturing macrophages with tumor cells increased HIF-1 and VEGF expression, which induced the dysregulation of arginase and Fizz1, and this was correlated with a gene signature found in alternatively activated macrophages that promote tumor development (9, 32).”
BackgroundInflammation and tumor progression: signaling pathways and targeted intervention
Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., & Li, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00658-5 · Cited by 2,792
Cited by
Cancer immune evasion, immunoediting and intratumour heterogeneity
Roerden, M., & Spranger, S. (2025) · Nature Reviews Immunology · doi:10.1038/s41577-024-01111-8 · Cited by 265
Macrophage Polarization and the Regulation of Bone Immunity in Bone Homeostasis
Hu, K., Shang, Z., Yang, X., Zhang, Y., & Cao, L. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s423819 · Cited by 192
Immunological factors linked to geographical variation in vaccine responses
van Dorst, M. M. A. R., Pyuza, J. J., Nkurunungi, G., Kullaya, V. I., Smits, H. H., Hogendoorn, P. C. W., Wammes, L. J., Everts, B., Elliott, A. M., Jochems, S. P., et al. (2023) · Nature reviews. Immunology · doi:10.1038/s41577-023-00941-2 · Cited by 90
Recent Advances in CAR-Based Solid Tumor Immunotherapy
Shin, M. H., Oh, E., Kim, Y. J., Nam, D.-H., Jeon, S., Yu, J. H., & Minn, D. (2023) · Cells · doi:10.3390/cells12121606 · Cited by 94
“As described earlier, CAR-M has phagocytic activity against solid tumors—similar to M1 macrophages in the TME [121,122,125].”
BackgroundInfluentialZhou, M., He, X., Mei, C., & Ou, C. (2023) · Biomarker Research · doi:10.1186/s40364-023-00538-w · Cited by 78
“Depending on their activation status, function, and secreted cytokines, macrophages can be categorized as one of two subtypes: M1 (pro-inflammatory, classically activated macrophages) and M2 (anti-inflammatory, alternatively activated macrophages) [15, 16].”
Background
Metadata
- Authors
- Zou, Z., Lin, H., Li, M., & Lin, B.
- Affiliations
- Hainan Medical University (CN)
- Corresponding author
- Li, Mengsen
- Lin, Bo
- ORCID
- Li, Mengsen
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2023-02-02
- Volume
- 13
- Pages
- 1103149-1103149
- ISSN
- 2234-943X (ISSN-L)
- PMC
- PMC9934926
- OpenAlex
- W4319793570
- Cited by
- 100
- References
- 95
- Citations by year
- 2026: 40 · 2025: 28 · 2024: 20 · 2023: 12
- FWCI
- 2.77
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Oncology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (82060514, 31560243, 81660463, 81560450, [2019]22, 20168263, 81960519)
- Natural Science Foundation of Hainan Province (821RC1065, 822RC700, 2019CR204, 2019CXTD406, 20168263, 820RC634, JBGS202106)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Keywords
- tumor-associated macrophages, macrophage polarization, tumor microenvironment, M1 macrophages, M2 macrophages, chronic inflammation, hypoxia, hypoxia-inducible factor, tumor progression, cancer immunotherapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tumor-associated macrophage polarization in the inflammatory tumor microenvironment. https://app.cochat.ai/papers/10.3389/fonc.2023.1103149
- The paper
- Zou, Z., Lin, H., Li, M., & Lin, B. (2023). Tumor-associated macrophage polarization in the inflammatory tumor microenvironment. Frontiers in Oncology. https://doi.org/10.3389/fonc.2023.1103149
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

